Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05215834
Other study ID # WonkwangUH9
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date March 1, 2021
Est. completion date November 30, 2021

Study information

Verified date January 2022
Source Wonkwang University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

1. Core body temperature is normally tightly regulated to within a few tenths of a degree. The major thermoregulatory defences in humans are sweating, arteriovenous shunt vasoconstriction, and shivering. 2. Inadvertent hypothermia often complicates prolonged surgery. In patients becoming sufficiently hypothermic, reemergence of thermoregulatory vasoconstriction usually prevents further core hypothermia. 3. The extent to which anesthetics reduce the vasoconstriction threshold depends on the type of drug and its concentration.


Description:

1. When propofol induces anesthesia, blood pressure decreases due to vasodilation, which is due to direct action on vascular smooth muscle and vasodilation due to blockage of the sympathetic nervous system. This results in a redistribution of body temperature, resulting in hypothermia. 2. The effects of remimazolam on the central nervous system, respiratory and cardiovascular system have been studied. Remimazolam, a new type of benzodiazepine drug acts on the GABA-A receptor and has the advantages of rapid induction, rapid recovery, stable hemodynamics, and mild respiratory inhibition. At present, there is little literature on its practice in intraoperative thermoregulation under general anesthesia. 3. Investigators hypothesized that the type of anesthetic agents might affect thermoregulatory mechanisms such as the redistribution of body heat, cutaneous heat loss or inhibition of thermoregulatory vasoconstriction. Therefore, Investigators investigated to compare remimazolam with propofol in core body temperature, vasoconstriction threshold and times to onset of vasoconstriction(min)in patients given laparoscopic assisted vaginal hysterectormy.


Recruitment information / eligibility

Status Completed
Enrollment 90
Est. completion date November 30, 2021
Est. primary completion date June 30, 2021
Accepts healthy volunteers No
Gender Male
Age group 19 Years to 75 Years
Eligibility Inclusion Criteria: 1. ASA physical classification I-III, 2. Patients who undergoing Robotic-assisted or laparoscopic (LRP) radical prostatectomy. Exclusion Criteria: 1. Patients who have Medications or any implanted device that could affect cardiovascular function 2. Patients who have a history with heat imbalance, thyroid diseases, dystautonomia, Raynaud's syndrome, uncontrolled diabetes mellitus, or hypertension.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Remifentanil
Remimazolm and Remifentanil (RR group): anesthesia was induced with remimazolam 6 mg/kg/h by continuous intravenous (IV) infusion and with the effect-site concentration of remifentanil 4 ng/ml and until the loss of consciousness (LoC), followed by remimazolam 1-2 mg/kg/h and remifentanil 3 ng/ml until the end of surgery. Propofol and Remifentanil (PR group), anesthesia was induced with the effect-site concentration of propofol of 6.0 µg/ml and remifentanil 4 ng/ml, and until the loss of consciousness (LoC), followed by the effect-site concentration of propofol of 2-4 µg/ml and remifentanil 3 ng/ml until the end of surgery.

Locations

Country Name City State
Korea, Republic of Wonkwag UH Iksan

Sponsors (1)

Lead Sponsor Collaborator
Wonkwang University Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary core body temperature change (°C) After the induction of general anesthesia, a nasopharyngeal temperature probe was inserted through the nasal cavity, and a 9.5- to 10.0-cm depth was set for optimal placement. The nasopharyngeal temperature was recorded every 10 min until the end of surgery at 60 minutes after induction of general anesthesia
Secondary times to onset of vasoconstriction (minute) time to arrive the skin temperature gradient (between forearm and index finger tip) equaled 0 °C. From after induction to until the end of surgery
Secondary intraoperative hypothermia core body temperature of <36 °C in patients undergoing anesthesia and surgery From after induction to until the end of surgery
Secondary Mean arterial pressure (mmHg) Mean arterial pressure From after induction to until the end of surgery
Secondary Heart rate (beats/min) Heart rate From after induction to until the end of surgery
Secondary vasoconstriction threshold (°C) the tympanic membrane temperature at which the skin temperature gradient (between forearm and index finger tip) equaled 0 °C From after induction to until the end of surgery
See also
  Status Clinical Trial Phase
Completed NCT05292937 - Incidence of Perioperative Hypothermia in Pediatric Patients
Not yet recruiting NCT05426278 - The Effect Of Intraoperative Forced Air Warmer Use, On Postoperative Nausea And Vomiting N/A
Completed NCT05516771 - Evaluation of a Licensed Double-sensor-heat-flux (DHF) Non-invasive Core Temperature Sensor in Small Children and Toddlers Undergoing Surgery
Completed NCT06010069 - The Relationship Between the Frequency of Intraoperative Hypothermia and Fragility Scores
Completed NCT03157609 - Can the SpotOn™ Zero-Heat-Flux-Thermometry Sensor Accurately Measure Core Temperature in Children? N/A
Recruiting NCT05349734 - Comparison of Underbody and Overbody Forced Air Blanket in Pediatric Patients Undergoing Cardiovascular Interventions N/A
Completed NCT04996407 - Survival Thermal Blanket Versus Draping Fabric to Prevent Hypothermia in Geriatric Surgical Patients N/A
Completed NCT03111875 - Perioperative Hypothermia and Myocardial Injury After Non-cardiac Surgery N/A
Completed NCT03527329 - Perioperative Hypothermia in Patients Submitted to Transurethral Resection
Not yet recruiting NCT05958550 - A Risk Prediction Model for Hypothermia After Laparoscopic Gastrointestinal Tumor Surgery
Completed NCT04252820 - Prevention of Perioperative Hypothermia in Transurethral Resection Under Spinal Anaesthesia N/A
Completed NCT04935632 - Perioperative Collection of Temperatures and Hypothermia
Completed NCT04709627 - enFlow IV Fluid and Blood Warming System
Not yet recruiting NCT05430997 - Hypothermia Risk Prediction Combined With Active Insulation Management in Geriatric Surgery N/A
Completed NCT04027842 - Effect of 10 Minute-prewarming on Core Body Temperature During Gynecologic Laparoscopic Surgery Under General Anesthesia N/A
Completed NCT05213377 - Preoperative Warming, Hypothermia and Functional Recovery in Total Hip Arthroplasty N/A
Completed NCT04686214 - Body Temperature and Perioperative Bleeding in Adolescent Idiopathic Scoliosis Surgery N/A
Recruiting NCT04410068 - Comparison of Electric Heating Pad Versus Forced-air Warming to Prevent Inadvertent Perioperative Hypothermia N/A
Recruiting NCT03473470 - Evaluation of the Active Warming Effects on Maternal and Neonatal Outcome During Cesarean Delivery N/A
Completed NCT04033900 - Effects of Active Prewarming in Perioperative Hypothermia in Adults N/A